Chitosan for High Cholesterol (Hyperlipidemia)
C Some Evidence Limited evidence from small studies, but some positive signals exist.Cochrane review of 14 RCTs: modest total cholesterol reduction (6-14 mg/dL). Clinical significance is debated. Fat-binding mechanism has theoretical appeal but limited practical impact.
The Bottom Line
Cochrane review of 14 RCTs: modest total cholesterol reduction (6-14 mg/dL). Clinical significance is debated. Fat-binding mechanism has theoretical appeal but limited practical impact.
Key Study Findings
Population: Rat model
Population: AlCl3-induced neurotoxicity rat model
Key Statistics
14
Studies
1100
Participants
Positive
Grade
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Commonly Used Dosages
- fatbinding:
- 1,500-3,000 mg/day before meals
- cholesterolsupport:
- 1,000-3,000 mg/day
Upper limit: Not formally established; GI side effects at higher doses
Dosages Studied in Research
| Dosage | Duration | Effect | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Positive | -- |
Best taken: 15-30 minutes before meals containing dietary fat
Safety & Side Effects
Reported Side Effects
- ⚠ Constipation
- ⚠ Gas and bloating
- ⚠ Nausea
- ⚠ Allergic reactions in those with shellfish allergy (contraindicated)
Known Interactions
- ● Fat-soluble vitamins (A, D, E, K — may reduce absorption)
- ● Oral medications (may bind and reduce absorption — separate by 2 hours)
- ● Warfarin (may reduce vitamin K absorption, affecting INR)
Tolerable upper intake: Not formally established; GI side effects at higher doses
Always consult your healthcare provider before starting any supplement.
Frequently Asked Questions
Does Chitosan help with High Cholesterol (Hyperlipidemia)?
How much Chitosan should I take for High Cholesterol (Hyperlipidemia)?
Are there side effects of Chitosan?
How strong is the evidence for Chitosan and High Cholesterol (Hyperlipidemia)?
Related Evidence
Other ingredients for High Cholesterol (Hyperlipidemia)
Chitosan for other conditions
References
- [1] Eman N Hosny et al.. Physiol Behav. 2024. Therapeutic effects of alpha lipoic acid and/or caffeine-loaded chitosan nanoparticles on memory impairment and neurochemical changes in high-fat diet-induced obese … doi:10.1016/j.physbeh.2024.114697 PubMed
- [2] Heba H Metwaly et al.. Toxicol Mech Methods. 2022. Chitosan and solid lipid nanoparticles enhance the efficiency of alpha-lipoic acid against experimental neurotoxicity. doi:10.1080/15376516.2021.1998275 PubMed
- [3] Norhayati Mohamed Noor et al.. Pharmaceutics. 2020. In Vitro Performance of Dutasteride-Nanostructured Lipid Carriers Coated with Lauric Acid-Chitosan Oligomer for Dermal Delivery. doi:10.3390/pharmaceutics12100994 PubMed
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.